IntelleWave Seeks to Improve Patient Care Through Cardiac Analysis
Written on Aug 19, 2010
If your body’s autonomic nervous system (ANS) is working properly, you probably won’t notice it. The ANS regulates involuntary functions including blood pressure, breathing, digestion, sleep, and the activity of vital organs such as the heart.
The ANS may also provide vital clues to patient...
The Ambitious Pipeline of EpiCept Corporation
Written on Aug 18, 2010
Cancer and chronic pain are two of the most widespread conditions afflicting humanity today. Developing therapeutics for either one of these targets is daunting enough for any life sciences company. But EpiCept Corporation (Nasdaq: EPCT), a Tarrytown, New York-based pharmaceutical company, is tackling...
Ascalon Leverages Experienced Management Team, Strategic Partnerships for Cancer Drug Development
Written on Aug 16, 2010
Ascalon International is a privately held oncology-focused drug development company based in Scottsdale, Arizona. Ascalon was established in June 2009 to create and manage a diversified portfolio of promising oncology drugs using cutting-edge development methodologies, pioneered by the company’s management...
CardioPolymers Continues Development on Heart Failure Device
Written on Aug 13, 2010
Congestive heart failure (CHF), a condition in which the heart loses functionality and blood-pumping capability, exacts a high cost on American society. CHF affects an estimated 5.8 million Americans and contributed to 282,574 deaths in 2006. In addition, heart failure is predicted to cost the U.S. $39.2...
Cardiogenesis Lightens the Situation for Angina Sufferers
Written on Aug 12, 2010
Would you let a surgeon aim a laser at your heart? The idea might be enough to give some patients palpitations. But Cardiogenesis, a medical device company that develops tools for the treatment of ischemic cardiac disease, has helped numerous heart-disease patients with the use of laser therapy.
One of the...
AesRx Aims at Two Rare Diseases In Growing Orphan Drug Market
Written on Aug 11, 2010
Orphan diseases are defined by the U.S. Food and Drug Administration as diseases affecting less than 200,000 people in the United States. Conditions that fall under the umbrella of orphan diseases include Huntington’s disease, Lou Gehrig’s disease, and muscular dystrophy. Although these conditions may...
Adventrx Pharmaceuticals Seeks to Improve Current Cancer Drugs
Written on Aug 10, 2010
Chemotherapy drugs are powerful anti-cancer agents, but they can also cause adverse side effects such as rashes, nausea, and allergic reactions. Reformulating a popular drug offers pharmaceutical companies the opportunity to preserve upon a drug’s known strengths while reducing its weaknesses....
TeleTracking Technologies: Fighting Hospital-Acquired Infections with Patient Flow Software
Written on Aug 9, 2010
Hospital-acquired infections (HAIs) are one of the biggest health hazards facing hospitals today. Statistics from the U.S. Centers for Disease Control indicate that HAIs, which can range from pneumonia to MRSA, cost hospitals up to $45 billion annually and kill an estimated 100,000 people per...



